India, March 21 -- image credit- freepik

Mumbai-based Alkem Laboratories has announced the launch of semaglutide injection in India under the brand names "Semasize", Obesema" and "Hepaglide". Semaglutide is administered as a subcutaneous injection, once weekly.

The company has launched its semaglutide pre-filled disposable injection pen at a price starting Rs 1,800 for a month's dosage, which translates into a weekly cost of Rs 450. Through an affordable pricing, Alkem aims to lower barriers to initiation and expand access to this therapy in India.

Alkem has received approval from the Drug Controller General of India (DCGI) for manufacturing and marketing semaglutide for type 2 diabetes mellitus and chronic weight management as an adju...